Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NexPharma AB
AB
Active
Org 5594926023
Mosshagestigen 220 Lgh 1001
Temporary employment agency activities and other human resource provisions · NACE 7820
Est. 2024
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 397K
EBITDA margin
56.7%
Equity ratio
56.8%
Financial strength
Net profit 2025
SEK 179K
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Key figures
Annual report 2025
Revenue
SEK 397K
—
EBITDA
SEK 226K
—
Net profit
SEK 179K
—
Total assets
SEK 359K
—
Equity
SEK 204K
—
Employees
—
—
Company information
Legal name
NexPharma AB
Org number
5594926023
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
13 augusti 2024
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget ska bedriva konsultverksamhet inom läkemedelsindustri och apotek.
Contact
Address
Mosshagestigen 220 Lgh 1001
Email
mohamed.hassan@nexpharma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Temporary employment agency activities and other human resource provisions
Companies in Salem
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
397
Staff expenses
−208
EBITDA
226
Depreciation & amort.
—
EBIT
226
Net financials
0
Profit before tax
226
Tax
−46
Net profit
179
Balance sheet
SEK thousands
Item
2025
Total assets
359
Equity
204
Long-term debt
—
Short-term debt
155
Total debt
155
Financial ratios
5-year trend
EBITDA margin
56.7%
This company
15.8%
Market median
+259% vs market
2025
2025
Equity ratio
56.8%
This company
38.2%
Market median
+49% vs market
2025
2025
Return on equity
87.8%
This company
18.4%
Market median
+377% vs market
2025
2025
Net profit margin
45.1%
This company
8.1%
Market median
+457% vs market
2025
2025
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
2025
2025
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-08-13 – 2025-04-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
HN
Hasnaa Nazem Jabbar
Chief Executive Officer
Chief Executive Officer
2024 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
HN
Hussein Nazem Jabbar
Deputy Board Member
2024
MH
Mohamed Hassan Hassan
Board of Directors
2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NexPharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Hasnaa Nazem Jabbar
Chief Executive Officer
0 companies
Hussein Nazem Jabbar
Deputy Board Member
0 companies
Mohamed Hassan Hassan
Board of Directors
0 companies